Similarly, treatment with anti-miR-134-3p or pcDNA3.1-LASP1 reversed the regulatory effect of si-PPP1R14B-AS1 on breast cancer cell migration (Fig. 8B) and invasion (Fig. 8C). Here, LASP1 is linked to breast carcinoma.